Christophe Bourdon
Chief Executive Officer at LEO Pharma A/S
Network origin in Christophe Bourdon first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.
14
| Subsidiary | Drugstore Chains | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christophe Bourdon via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
LEO Fondet
 LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Public Communications Contact Director of Finance/CFO Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NNIT A/S | Information Technology Services | Director/Board Member Chairman | |
| ViiV Healthcare Co. | Corporate Officer/Principal | ||
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Chairman | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Director of Finance/CFO | |
| University of Aarhus | College/University | Graduate Degree | |
| SCANDINAVIAN INVESTMENT GROUP A/S | Real Estate Investment Trusts | Director/Board Member | |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
| XSpray Pharma Futurum AB | Corporate Officer/Principal | ||
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Chairman | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman | |
| Sällheten Invest AB | Director/Board Member | ||
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Elypta AB develops the first metabolism-based liquid biopsy platform enabling early detection and closer follow-up of cancer. The company was founded by Francesco Gatto and Jens Nielsen in 2017 and is headquartered in Stockholm, Sweden. | Packaged Software | Chairman | |
| NxtScience AB | Director/Board Member | ||
Forska Sverige
 Forska Sverige Miscellaneous Commercial ServicesCommercial Services Forska Sverige provides medical research services. | Miscellaneous Commercial Services | Director/Board Member | |
| Vetenskapsrådet | Director/Board Member | ||
Allergan France SAS
 Allergan France SAS Pharmaceuticals: MajorHealth Technology Allergan France SAS engages in the research, development, and manufacture of pharmaceutical products. The company was founded in 1978 and is headquartered in Courbevoie, France. | Pharmaceuticals: Major | President | |
| MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Chairman | |
| Viscogel AB | Director/Board Member | ||
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Karolinska University Hospital is a premier health facility and one of Europe's largest teaching hospitals located in Stockholm, Sweden. The Swedish company provides healthcare services for a wide range of disorders, from major public health diseases to rare medical conditions. As a designated provider of highly specialized medical services, they have a primary responsibility for the clinical components of research and education. Together with the world-respected Karolinska Institutet, they lead in medical breakthroughs. The company educates and train tomorrow's medical specialists and healthcare professionals as a major teaching hospital. | Hospital/Nursing Management | Chairman | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
Modul 1 Data AB
 Modul 1 Data AB Information Technology ServicesTechnology Services Modul 1 Data AB offers consulting and professional services. The firm provides knowledge-specific IT solutions and industry-specific business and eServices. Its IT consulting group develops, provides quality assurance and maintenance of business supporting IT solutions. The company was founded in 1991 and is headquartered in Stockholm, Sweden. | Information Technology Services | Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Executive Officer | |
| PHARNEXT SCA | Biotechnology | Chairman | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Oxford University Medical School | College/University | Doctorate Degree | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
UNION Therapeutics A/S
 UNION Therapeutics A/S Pharmaceuticals: MajorHealth Technology Union Therapeutics A/S operates as a clinical stage pharmaceutical company which focuses on the treatment of inflammatory skin disease. It also centers in the development of molecules exhibiting immunological and microbiological effects. The company is headquartered in Hellerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
| Queen's University | College/University | Undergraduate Degree | |
Novo Nordisk Canada, Inc.
 Novo Nordisk Canada, Inc. Pharmaceuticals: MajorHealth Technology Novo Nordisk Canada, Inc. provides healthcare services. The firm specializes in the areas of coagulation disorders, growth disorders and hormone replacement therapy. The company was founded in 1993 and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | President | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member | |
Ventac Partners GmbH
 Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Epics Therapeutics SA
 Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| Sweden | 25 |
| Denmark | 9 |
| United Kingdom | 6 |
| United States | 5 |
| France | 4 |
Sectoral
| Health Technology | 26 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 4 |
| Technology Services | 4 |
Operational
| Director/Board Member | 94 |
| Chairman | 30 |
| Corporate Officer/Principal | 22 |
| Independent Dir/Board Member | 16 |
| Chief Executive Officer | 12 |
Most connected contacts
| Insiders | |
|---|---|
| Jesper Brandgaard | 28 |
| Anders Olof Adolf Ekblom | 27 |
| Peter Helt Jacobsen Haahr | 21 |
| Jesper Mailind | 16 |
| Lena Elisabeth Svanberg | 16 |
| Jan van de Winkel | 15 |
| Paul Navarre | 10 |
| Lars Green | 9 |
| Monica Shaw | 8 |
| Jonas Agnblad | 6 |
| Christine Garrett | 5 |
| Jannie Kogsbøll | 4 |
| Brian Hilberdink | 4 |
| Franck Maréno | 3 |
| Keith Bernius | 2 |
- Stock Market
- Insiders
- Christophe Bourdon
- Company connections
